BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37330122)

  • 1. Preventing eviction during pregnancy: a cost-effectiveness analysis of a theoretical safety-net program.
    Mandelbaum A; Dzubay S; Chaiken SR; Doshi U; Katlaps I; Caughey AB
    Am J Obstet Gynecol; 2023 Sep; 229(3):331.e1-331.e9. PubMed ID: 37330122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating Mild Chronic Hypertension During Pregnancy: A Cost-Effectiveness Analysis.
    Doshi U; Chaiken S; Hersh A; Gibbins KJ; Caughey AB
    Obstet Gynecol; 2024 Apr; 143(4):562-569. PubMed ID: 38387029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetoscopic compared with open repair of myelomeningocele: a 2-delivery cost-effectiveness analysis.
    Packer CH; Hersh AR; Caughey AB
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100434. PubMed ID: 34217856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of perinatal depression with counseling in adolescents: a cost-effectiveness analysis.
    Franta G; Hersh AR; Cirino NH; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9593-9599. PubMed ID: 35282745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of influenza vaccination during pregnancy.
    Chaiken SR; Hersh AR; Zimmermann MS; Ameel BM; Layoun VR; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5244-5252. PubMed ID: 33478281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial.
    WHO ACTION Trial Collaborators
    Lancet Glob Health; 2022 Oct; 10(10):e1523-e1533. PubMed ID: 36113535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impacts of rent burden and eviction on mortality in the United States, 2000-2019.
    Graetz N; Gershenson C; Porter SR; Sandler DH; Lemmerman E; Desmond M
    Soc Sci Med; 2024 Jan; 340():116398. PubMed ID: 38007965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis.
    Hersh AR; Skeith AE; Sargent JA; Caughey AB
    Am J Obstet Gynecol; 2019 Jun; 220(6):590.e1-590.e10. PubMed ID: 30768934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral Smoking Cessation Counseling During Pregnancy: A Cost-Effectiveness Analysis.
    Bacheller HL; Hersh AR; Caughey AB
    Obstet Gynecol; 2021 Apr; 137(4):703-712. PubMed ID: 33706341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero exposure to threat of evictions and preterm birth: Evidence from the United States.
    Khadka A; Fink G; Gromis A; McConnell M
    Health Serv Res; 2020 Oct; 55 Suppl 2(Suppl 2):823-832. PubMed ID: 32976630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Selection Into Eviction: Adverse Birth Outcomes and Children's Risk of Eviction Through Age 5 Years.
    Schwartz GL; Leifheit KM; Berkman LF; Chen JT; Arcaya MC
    Am J Epidemiol; 2021 Jul; 190(7):1260-1269. PubMed ID: 33454765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of low-dose aspirin for the prevention of preterm birth: a prospective study of the Global Network for Women's and Children's Health Research.
    Patterson JK; Neuwahl S; Goco N; Moore J; Goudar SS; Derman RJ; Hoffman M; Metgud M; Somannavar M; Kavi A; Okitawutshu J; Lokangaka A; Tshefu A; Bose CL; Mwapule A; Mwenechanya M; Chomba E; Carlo WA; Chicuy J; Figueroa L; Krebs NF; Jessani S; Saleem S; Goldenberg RL; Kurhe K; Das P; Patel A; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Bucher S; Liechty EA; Bresnahan BW; Koso-Thomas M; McClure EM
    Lancet Glob Health; 2023 Mar; 11(3):e436-e444. PubMed ID: 36796987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic hypothermia in severe hypoxic-ischemic encephalopathy: a cost-effectiveness analysis.
    Packer CH; Hersh AR; Sargent JA; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):890-897. PubMed ID: 32156180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of gestational surrogates for women with Eisenmenger syndrome: a cost-effectiveness analysis.
    Clennon EK; Pare E; Amato P; Caughey AB
    J Matern Fetal Neonatal Med; 2021 Feb; 34(4):526-531. PubMed ID: 31006283
    [No Abstract]   [Full Text] [Related]  

  • 16. Living in a block group with a higher eviction rate is associated with increased odds of preterm delivery.
    Freedman AA; Smart BP; Keenan-Devlin LS; Borders A; Ernst LM; Miller GE
    J Epidemiol Community Health; 2022 Apr; 76(4):398-403. PubMed ID: 34607891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cervical length screening and progesterone treatment to prevent spontaneous preterm delivery in Sweden.
    Wikström T; Kuusela P; Jacobsson B; Hagberg H; Lindgren P; Svensson M; Wennerholm UB; Valentin L
    Ultrasound Obstet Gynecol; 2022 Jun; 59(6):778-792. PubMed ID: 35195310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort.
    Burchard J; Markenson GR; Saade GR; Laurent LC; Heyborne KD; Coonrod DV; Schoen CN; Baxter JK; Haas DM; Longo SA; Sullivan SA; Wheeler SM; Pereira LM; Boggess KA; Hawk AF; Crockett AH; Treacy R; Fox AC; Polpitiya AD; Fleischer TC; Garite TJ; Jay Boniface J; Zupancic JAF; Critchfield GC; Kearney PE
    J Med Econ; 2022; 25(1):1255-1266. PubMed ID: 36377363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder.
    Robin AM; Hersh AR; John C; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4918-4926. PubMed ID: 33455473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.